Amanote Research
Register
Sign In
Relapse in Multiple Sclerosis
British Medical Journal
- United Kingdom
doi 10.1136/bmj.h1765
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
April 14, 2015
Authors
I. Galea
N. Ward-Abel
C. Heesen
Publisher
BMJ
Related search
Menarche Increases Relapse Risk in Pediatric Multiple Sclerosis
Multiple Sclerosis
Neurology
How to Run a Multiple Sclerosis Relapse Clinic
Practical Neurology
Medicine
Neurology
Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
The Lived Experience of Multiple Sclerosis Relapse: How Adults With Multiple Sclerosis Processed Their Relapse Experience and Evaluated Their Need for Postrelapse Care
Multiple Sclerosis International
Neurology
Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod
PLoS ONE
Multidisciplinary
The Multiple Sclerosis Relapse Experience: Patient-Reported Outcomes From the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry
BMC Neurology
Medicine
Neurology
Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis
Journal of Central Nervous System Disease
Commentary: Acute Hemorrhagic Leukoencephalitis (Weston–Hurst Syndrome) in a Patient With Relapse-Remitting Multiple Sclerosis
Frontiers in Immunology
Allergy
Immunology
Pnd57 - The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
